Daily Newsletter

24 November 2023

Daily Newsletter

24 November 2023

Trillium and Sectra partner to integrate AI into diagnostic imaging

The initiative aims to detect serious health conditions earlier and enable timely intervention.

November 23 2023

Canadian hospital network Trillium Health Partners (THP) has partnered with Sectra, a medical imaging IT and cybersecurity company based in Sweden, to integrate artificial intelligence (AI) into diagnostic imaging.

Through the Cloud-hosted AI service Sectra Amplifier Services, THP aims to implement AI workflows into its diagnostic imaging department.

THP will be able to access validated third-party AI applications through the service for trial and evaluation before adoption.

This initiative aims to detect serious health conditions earlier, enabling timely intervention and improving health outcomes.

Trillium Health Partners programme chief and medical director diagnostic imaging Dr Ivan Diamond said: “This technology will enable THP to expedite the diagnosis and treatment of potentially fatal conditions where every minute counts for improved patient outcomes.

“We are proud to be the first Canadian adopter of this cutting-edge technology, which has the potential to reinvent how care is delivered within our walls and beyond.

“Using the Sectra Amplifier Service to deploy this tool has significantly simplified the process in integrating AI into our workflow.”

The partnership establishes THP as the first Canadian customer to connect its Sectra Enterprise Imaging PACS to Sectra Amplifier Services.

Sectra's enterprise imaging offers a unified strategy for imaging needs, contributing to efficient care, and reduced operational costs.

Sectra Canada president Nader Soltani said: “Over the last five years, AI has been a hot topic within healthcare, and we are seeing the early adopters; predominantly in diagnostic imaging.

“It is encouraging to see Canadian hospitals embrace AI for both research and clinical use, leading to higher-quality patient care for our population.

“Sectra is committed to serving our customers on their journeys towards AI adoption.”

Based in Linköping, Sectra sells its products directly in 19 countries and registered total sales of Skr2.35bn ($224m) in the last fiscal year.

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials. While the current marketed drug space for ARF has only a handful of treatment options, currently available mid-to-late-stage pipeline drugs are likely to pave the way for a new treatment approach in the future.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close